SCHEMBL1069680

SCHEMBL1069680

O=C1NC(c2cc(F)cc(F)c2)CCC12CCCC2

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.33
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978141 1.00 RIPK1 (0.33) RIPK1TDP1
SCHEMBL549324 0.81 GABRP (0.34) TDP1
SCHEMBL549323 0.81 GABRP (0.34) TDP1
SCHEMBL4346918 0.77 KDM1A (0.32)
SCHEMBL979115 0.77 KDM1A (0.32)
SCHEMBL10153650 0.75 CALCRL (0.35)
SCHEMBL12950635 0.75 CALCRL (0.35)
SCHEMBL4355728 0.72 SLC6A9 (0.34)
SCHEMBL3592708 0.72 SLC6A9 (0.34)
SCHEMBL1069083 0.71 PDE4A (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2271346-A2 MONOCYCLIC CGRP RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2011-01-12 EP disclosed
WO-2009120652-A2 MONOCYCLIC CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2009-10-01 WO disclosed